Glaxosmithkline Pharmaceuticals Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Total Qtr Revenue cr | 1,073.38 | 1,013.51 | 848.89 | 1,015.05 | 984.49 |
| Other Income Qtr Cr | 32.12 | 33.57 | 43.72 | 40.68 | 35.07 |
| Operating Revenues Qtr | 1,041.26 | 979.94 | 805.17 | 974.37 | 949.42 |
Loading chart... | |||||
Operating Expenses Qtr | 669.92 | 644.21 | 553.97 | 641.18 | 657.50 |
Operating Profit Qtr | 371.34 | 335.73 | 251.20 | 333.19 | 291.92 |
EBITDA Qtr Cr | 421.44 | 371.94 | 294.92 | 373.87 | 326.99 |
Depreciation Qtr | 20.32 | 17.43 | 15.52 | 14.72 | 18.80 |
Net Profit Qtr | 295.62 | 257.49 | 205.01 | 262.87 | 229.88 |
Basic EPS Qtr | 16.54 | 15.20 | 12.10 | 15.52 | 13.57 |
Open Demat Account